Core Laboratories Inc. Revenue 2021–2025
Core Laboratories Inc. annual/quarterly revenue history and growth rate from 2021 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Core Laboratories Inc. revenue for the quarter ending March 31, 2026 was 121.8 M, a 1.45% decrease year-over-year.
- Core Laboratories Inc. revenue for the twelve months ending March 31, 2026 was 510.1 M, a 1.90% decrease year-over-year.
- Core Laboratories Inc. annual revenue for 2025 was 526.5 M, a 0.51% increase from 2024.
- Core Laboratories Inc. annual revenue for 2024 was 523.8 M, a 2.76% increase from 2023.
- Core Laboratories Inc. annual revenue for 2023 was 509.8 M, a 4.10% increase from 2022.
- Core Laboratories Inc. annual revenue for 2022 was 489.7 M.
Core Laboratories Inc. (CLB) — Frequently Asked Questions
Core Laboratories Inc. (CLB) is a publicly traded US company. It has a market capitalization of $631M. In fiscal 2025 it reported revenue of $527M and net income of $30M. Explore CLB's stock price, financial statements, earnings history, margins and key ratios below.
What is Core Laboratories Inc.'s market cap?
Core Laboratories Inc. (CLB) has a market capitalization of $631M.
What is the CLB stock price?
CLB trades at $13.42 (+1.13% on the day).
How much revenue does Core Laboratories Inc. make?
Core Laboratories Inc. reported revenue of $527M in fiscal 2025.
Is CLB profitable?
In fiscal 2025, Core Laboratories Inc. reported net income of $30M.